| - GRCh37:
- Chr1:33246629-33248160
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Mar 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33256743-33272232
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Mar 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33247985-33248160
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Oct 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33248074
- GRCh38:
- Chr1:32782473
| YARS1 | R325W | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33263447
- GRCh38:
- Chr1:32797846
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Jul 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33272131
- GRCh38:
- Chr1:32806530
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Apr 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33263391
- GRCh38:
- Chr1:32797790
| YARS1 | Q188H | Charcot-Marie-Tooth disease dominant intermediate C, Inborn genetic diseases | Uncertain significance (Oct 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:33245895
- GRCh38:
- Chr1:32780294
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Benign (Apr 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33244963
- GRCh38:
- Chr1:32779362
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33276301
- GRCh38:
- Chr1:32810700
| YARS1 | E91Q | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Jul 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33263347
- GRCh38:
- Chr1:32797746
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Jun 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33276615
- GRCh38:
- Chr1:32811014
| YARS1 | R34Q | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Oct 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33241709-33241710
- GRCh38:
- Chr1:32776108-32776109
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Apr 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33241590
- GRCh38:
- Chr1:32775989
| YARS1 | I527V | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Oct 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33276378
- GRCh38:
- Chr1:32810777
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Sep 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33252033
- GRCh38:
- Chr1:32786432
| LOC126805688, YARS1 | R279Q | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Aug 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33241606
- GRCh38:
- Chr1:32776005
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Aug 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33248147
- GRCh38:
- Chr1:32782546
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (May 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33245110
- GRCh38:
- Chr1:32779509
| YARS1 | R450L | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Aug 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33247985
- GRCh38:
- Chr1:32782384
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C, not provided | Likely benign (Oct 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:33276384
- GRCh38:
- Chr1:32810783
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Mar 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33256777
- GRCh38:
- Chr1:32791176
| YARS1 | S224G | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Apr 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33252646
- GRCh38:
- Chr1:32787045
| LOC126805688, YARS1 | E239K | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Oct 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33246765
- GRCh38:
- Chr1:32781164
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33246711
- GRCh38:
- Chr1:32781110
| YARS1 | P360A | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33263344
- GRCh38:
- Chr1:32797743
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Apr 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33282788
- GRCh38:
- Chr1:32817187
| S100PBP, YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33252553
- GRCh38:
- Chr1:32786952
| YARS1, LOC126805688 | P270A | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Apr 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33245020
- GRCh38:
- Chr1:32779419
| YARS1 | E480G | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (May 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33276324
- GRCh38:
- Chr1:32810723
| YARS1 | M83T | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Apr 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33272177
- GRCh38:
- Chr1:32806576
| YARS1 | V139A | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (May 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33276278
- GRCh38:
- Chr1:32810677
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Aug 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33245692
- GRCh38:
- Chr1:32780091
| YARS1 | A443D | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33245106
- GRCh38:
- Chr1:32779505
| YARS1 | Q451H | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Feb 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33282792
- GRCh38:
- Chr1:32817191
| S100PBP, YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Jun 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33245063
- GRCh38:
- Chr1:32779462
| YARS1 | H466D | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (May 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33276241
- GRCh38:
- Chr1:32810640
| YARS1 | P111S | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Jul 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33276242
- GRCh38:
- Chr1:32810641
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33252624
- GRCh38:
- Chr1:32787023
| LOC126805688, YARS1 | K246R | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (May 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33245019-33245021
- GRCh38:
- Chr1:32779418-32779420
| YARS1 | E480del | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33252036
- GRCh38:
- Chr1:32786435
| LOC126805688, YARS1 | L278P | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Dec 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33252635-33252643
- GRCh38:
- Chr1:32787034-32787042
| LOC126805688, YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33245074
- GRCh38:
- Chr1:32779473
| YARS1 | A462G | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Oct 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33272207
- GRCh38:
- Chr1:32806606
| YARS1 | Y129C | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Oct 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33245122
- GRCh38:
- Chr1:32779521
| YARS1 | E446V | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Sep 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33245825
- GRCh38:
- Chr1:32780224
| YARS1 | P399S | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Sep 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33256825
- GRCh38:
- Chr1:32791224
| YARS1 | V208I | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33246636
- GRCh38:
- Chr1:32781035
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Jun 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33252634
- GRCh38:
- Chr1:32787033
| LOC126805688, YARS1 | K243E | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33263460
- GRCh38:
- Chr1:32797859
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Jun 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33272127
- GRCh38:
- Chr1:32806526
| YARS1 | V156M | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Jul 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33246667
- GRCh38:
- Chr1:32781066
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (May 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33248102
- GRCh38:
- Chr1:32782501
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Mar 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33272223
- GRCh38:
- Chr1:32806622
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Apr 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33276662
- GRCh38:
- Chr1:32811061
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Sep 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33245059
- GRCh38:
- Chr1:32779458
| YARS1 | V467G | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Oct 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33245016
- GRCh38:
- Chr1:32779415
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (May 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33252030
- GRCh38:
- Chr1:32786429
| LOC126805688, YARS1 | D280G | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Jul 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33252546
- GRCh38:
- Chr1:32786945
| LOC126805688, YARS1 | K272R | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (May 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33248069
- GRCh38:
- Chr1:32782468
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Jun 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33276383
- GRCh38:
- Chr1:32810782
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Apr 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33248057
- GRCh38:
- Chr1:32782456
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Aug 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33248014
- GRCh38:
- Chr1:32782413
| YARS1 | S345A | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Feb 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33245855
- GRCh38:
- Chr1:32780254
| YARS1 | V389I | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Apr 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33276496
- GRCh38:
- Chr1:32810895
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Jan 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33245796
- GRCh38:
- Chr1:32780195
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Jan 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33276652
- GRCh38:
- Chr1:32811051
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Oct 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33276385
- GRCh38:
- Chr1:32810784
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Aug 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33245798
- GRCh38:
- Chr1:32780197
| YARS1 | Q408* | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Jan 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33248061
- GRCh38:
- Chr1:32782460
| YARS1 | N329S | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Aug 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33244988
- GRCh38:
- Chr1:32779387
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Jan 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33276591
- GRCh38:
- Chr1:32810990
| YARS1 | T42M | Inborn genetic diseases, Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Aug 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:33276282
- GRCh38:
- Chr1:32810681
| YARS1 | Y97C | Charcot-Marie-Tooth disease dominant intermediate C, Neurodevelopmental delay | Conflicting interpretations of pathogenicity (Jun 28, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:33248069
- GRCh38:
- Chr1:32782468
| YARS1 | E326D | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Sep 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33282804
- GRCh38:
- Chr1:32817203
| S100PBP, YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Dec 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33282802
- GRCh38:
- Chr1:32817201
| S100PBP, YARS1 | T15N | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33282788
- GRCh38:
- Chr1:32817187
| S100PBP, YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Oct 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33282785
- GRCh38:
- Chr1:32817184
| S100PBP, YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (May 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33282779
- GRCh38:
- Chr1:32817178
| S100PBP, YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Feb 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33276663
- GRCh38:
- Chr1:32811062
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Apr 5, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33276624
- GRCh38:
- Chr1:32811023
| YARS1 | L31P | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Oct 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33276590
- GRCh38:
- Chr1:32810989
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33276514-33276522
- GRCh38:
- Chr1:32810913-32810921
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Oct 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33276496
- GRCh38:
- Chr1:32810895
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33276332
- GRCh38:
- Chr1:32810731
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33276307
- GRCh38:
- Chr1:32810706
| YARS1 | L89F | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33276246
- GRCh38:
- Chr1:32810645
| YARS1 | G109D | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Aug 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33276179
- GRCh38:
- Chr1:32810578
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Sep 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33272198
- GRCh38:
- Chr1:32806597
| YARS1 | D132V | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33272142
- GRCh38:
- Chr1:32806541
| YARS1 | E151K | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Sep 8, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33272101
- GRCh38:
- Chr1:32806500
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33272092
- GRCh38:
- Chr1:32806491
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Oct 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33272092
- GRCh38:
- Chr1:32806491
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Jul 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33263462
- GRCh38:
- Chr1:32797861
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33263368
- GRCh38:
- Chr1:32797767
| YARS1 | E196G | Charcot-Marie-Tooth disease dominant intermediate C, Inborn genetic diseases | Uncertain significance (Dec 12, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:33263361
- GRCh38:
- Chr1:32797760
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Jul 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33256861
- GRCh38:
- Chr1:32791260
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33256827
- GRCh38:
- Chr1:32791226
| YARS1 | R207Q | Inborn genetic diseases, Charcot-Marie-Tooth disease dominant intermediate C | Conflicting interpretations of pathogenicity (Aug 7, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr1:33256826
- GRCh38:
- Chr1:32791225
| YARS1 | | Charcot-Marie-Tooth disease dominant intermediate C | Likely benign (May 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:33256805
- GRCh38:
- Chr1:32791204
| YARS1 | M214I | Charcot-Marie-Tooth disease dominant intermediate C | Uncertain significance (Nov 29, 2021) | criteria provided, single submitter |